[go: up one dir, main page]

DE69632536D1 - Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren - Google Patents

Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren

Info

Publication number
DE69632536D1
DE69632536D1 DE69632536T DE69632536T DE69632536D1 DE 69632536 D1 DE69632536 D1 DE 69632536D1 DE 69632536 T DE69632536 T DE 69632536T DE 69632536 T DE69632536 T DE 69632536T DE 69632536 D1 DE69632536 D1 DE 69632536D1
Authority
DE
Germany
Prior art keywords
rsv
vectors
respiratory syncytial
syncytial virus
vaccinals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69632536T
Other languages
English (en)
Inventor
Xiaomao Li
E Ewasyshyn
Suryaprakash Sambhara
H Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur Ltd
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23891664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69632536(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur Ltd, Aventis Pasteur SA filed Critical Aventis Pasteur Ltd
Application granted granted Critical
Publication of DE69632536D1 publication Critical patent/DE69632536D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69632536T 1995-06-07 1996-06-07 Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren Expired - Lifetime DE69632536D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/476,397 US6019980A (en) 1995-06-07 1995-06-07 Nucleic acid respiratory syncytial virus vaccines
PCT/CA1996/000398 WO1996040945A2 (en) 1995-06-07 1996-06-07 Nucleic acid respiratory syncytial virus vaccines

Publications (1)

Publication Number Publication Date
DE69632536D1 true DE69632536D1 (de) 2004-06-24

Family

ID=23891664

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69632536T Expired - Lifetime DE69632536D1 (de) 1995-06-07 1996-06-07 Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren

Country Status (9)

Country Link
US (5) US6019980A (de)
EP (1) EP0832253B9 (de)
JP (1) JPH11507808A (de)
AT (1) ATE267258T1 (de)
AU (1) AU695527B2 (de)
BR (1) BR9608615A (de)
CA (1) CA2223610A1 (de)
DE (1) DE69632536D1 (de)
WO (1) WO1996040945A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465574B2 (en) 1994-09-30 2008-12-16 Medimmune, Llc Recombinant RSV virus expression systems and vaccines
US6083925A (en) * 1995-06-07 2000-07-04 Connaught Laboratories Limited Nucleic acid respiratory syncytial virus vaccines
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6797276B1 (en) 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US6060308A (en) * 1997-09-04 2000-05-09 Connaught Laboratories Limited RNA respiratory syncytial virus vaccines
US6830748B1 (en) 1997-09-26 2004-12-14 Medimmune Vaccines, Inc. Recombinant RSV virus expression systems and vaccines
EP1707633A1 (de) * 1997-11-14 2006-10-04 Sanofi Pasteur Limited Alphavirus-Vektoren als Impfstoffe gegen Paramyxovirus
CA2309835A1 (en) * 1997-11-14 1999-05-27 Connaught Laboratories Limited Alphavirus vectors
EP1034289A1 (de) 1997-11-14 2000-09-13 Connaught Laboratories Limited Alphavirus-vektoren als impfstoffe gegen paramyxovirus
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US6656906B1 (en) 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6258782B1 (en) 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
AR030019A1 (es) * 1999-05-18 2003-08-13 Smithkline Beecham Corp Anticuerpos monoclonales humanos y fragmentos funcionales del mismo, un procedimiento para su produccion, composiciones farmaceuticas que los comprenden, una molecula aislada de acido nucleico, un plasmido recombinante, una celula hospedante y el uso de dichos anticuerpos para la manufactura de un m
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
WO2001047551A2 (en) * 1999-12-01 2001-07-05 Chiron Corporation Eliciting antibodies specific for hepatitis c virus (hcv)
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
WO2001045639A2 (en) * 1999-12-22 2001-06-28 The Ohio State University Research Foundation Methods for protecting against lethal infection with bacillus anthracis
US7078388B2 (en) * 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
DE60136334D1 (en) 2000-02-02 2008-12-11 Us Health Cd40-ligand als adjuvant für respiratorisches syncytialvirus-impfstoff
US6623741B1 (en) * 2000-02-29 2003-09-23 Trimeris, Inc. Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission
US6656700B2 (en) * 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
US6686188B2 (en) 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
AU2002250071B2 (en) 2001-02-13 2008-02-14 Government Of The United States, As Represented By The Secretary Of The Army Vaccine for transcutaneous immunization
TW200636064A (en) * 2004-10-28 2006-10-16 Centocor Inc Anti-respiratory syncytial virus antibodies, antigens and uses thereof
US7118427B2 (en) * 2004-12-30 2006-10-10 Homac Mfg Company Electrical connector including removable tether and cap assemblies and associated methods
CA2630860A1 (en) * 2005-11-25 2007-05-31 Galapagos Sas Urea derivatives useful as calcium receptor modulators
DE102006060799A1 (de) * 2006-12-21 2008-06-26 RUHR-UNIVERSITäT BOCHUM RSV F-Protein und seine Verwendung
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
EP2069400A4 (de) * 2007-06-26 2012-03-07 Medimmune Llc Verfahren zur behandlung von rsv-infektionen und verwandten erkrankungen
NZ619953A (en) 2008-07-16 2015-06-26 Inst Research In Biomedicine Human cytomegalovirus neutralizing antibodies and use thereof
US8460680B2 (en) * 2009-04-24 2013-06-11 National Health Research Institutes Polyvalent chimeric rubella virus-based vaccines
JP5806233B2 (ja) * 2009-12-21 2015-11-10 コーネル ユニバーシティＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ 新規ニューモウィルス組成物及びその使用方法
NZ704005A (en) 2012-08-01 2016-07-29 Bavarian Nordic As Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
EP3586871A3 (de) 2013-08-21 2020-03-11 CureVac AG Impfstoff gegen das respiratorische synzytialvirus
EP4477231A3 (de) 2013-08-21 2025-03-19 CureVac SE Kombinationsimpfstoff
WO2015048115A1 (en) 2013-09-25 2015-04-02 Zoetis Llc Pcv2b divergent vaccine composition and methods of use
ES2922760T3 (es) 2015-10-22 2022-09-20 Modernatx Inc Vacunas de virus respiratorios
WO2017175000A1 (en) * 2016-04-08 2017-10-12 Pulmocide Limited Compounds
WO2018170260A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Respiratory syncytial virus vaccine
MA54676A (fr) 2018-01-29 2021-11-17 Modernatx Inc Vaccins à base d'arn contre le vrs
CA3091558A1 (en) 2018-04-17 2019-10-24 Curevac Ag Novel rsv rna molecules and compositions for vaccination

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149650A (en) * 1986-01-14 1992-09-22 University Of North Carolina At Chapel Hill Vaccines for human respiratory virus
ES2116269T3 (es) 1989-03-21 1998-07-16 Vical Inc Expresion de secuencias exogenas de polinucleotidos en un vertebrado.
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5195510A (en) * 1990-07-30 1993-03-23 Svacina Lawrence M Deep pressure massage device
AU9128391A (en) * 1990-11-05 1992-05-26 Siba Kumar Samal Bovine respiratory syncytial virus genes
DK0584279T3 (da) * 1991-05-14 2001-06-11 Immune Response Corp Inc Målrettet aflevering af gener, som koder for immunogene proteiner
IL105456A (en) * 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
IL108915A0 (en) 1993-03-18 1994-06-24 Merck & Co Inc Polynucleotide vaccine against influenza virus
CN1132516A (zh) * 1993-07-30 1996-10-02 奥拉维克斯公司 抗呼吸道合胞体病毒的单克隆IgA抗体

Also Published As

Publication number Publication date
ATE267258T1 (de) 2004-06-15
US5880104A (en) 1999-03-09
EP0832253B9 (de) 2004-12-22
US6677127B1 (en) 2004-01-13
US6022864A (en) 2000-02-08
BR9608615A (pt) 1999-06-15
US5843913A (en) 1998-12-01
JPH11507808A (ja) 1999-07-13
EP0832253B1 (de) 2004-05-19
WO1996040945A2 (en) 1996-12-19
US6019980A (en) 2000-02-01
CA2223610A1 (en) 1996-12-19
WO1996040945A3 (en) 1997-01-23
EP0832253A2 (de) 1998-04-01
AU6117696A (en) 1996-12-30
AU695527B2 (en) 1998-08-13

Similar Documents

Publication Publication Date Title
DE69632536D1 (de) Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
ZA91134B (en) New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses
EP0256092A4 (de) Abgeschwächte herpesviren, herpesviren, die eine für aminosäuresequenzen kodierende fremd-dns enthalten, sowie impfstoffe, die diese enthalten.
MXPA01008966A (es) Vacunas contra el virus sincicial respiratorio a base de acido nucleico.
ATE312920T1 (de) Dna immunisierung gegen chlamydia infektion
CA2190473A1 (en) Recombinant papilloma virus l1
EP1847549A3 (de) Polyproteinkonstrukte des Papillomavirus
ES557358A0 (es) Un metodo para la deteccion de anticuerpos especificos de un virus lav en un fluido biologico.
IE811463L (en) Interferons
WO2000006738A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
WO2000006736A3 (en) Nucleic acids and proteins from group b streptococcus
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
DK610888D0 (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
WO2001032882A3 (en) Nucleic acids and proteins from group b streptococcus
GB9409985D0 (en) Vaccine against mycobacterial infections
BR9815496A (pt) Vacinas de ácido nucléico que codificam proteìna gde vìrus sincicial respiratório
EP0816504A3 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
WO1999051745A3 (en) Dna immunization against chlamydia infection
MX9709525A (es) Vacunas de virus sincicial respiratorio de acido nucleico.
WO1995020658A3 (en) Diagnosis and treatment of infections due to streptococci and enterococci
WO1998023752A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen

Legal Events

Date Code Title Description
8332 No legal effect for de